Form 4: Bausch + Lomb Executive Reports Routine Share Withholding for Tax Obligations

Luc Bonnefoy, President of Surgical at Bausch + Lomb Corporation, reported a routine disposition of 968 common shares valued at $12.33 per share to cover tax withholding obligations related to the vesting of restricted share units.

Summary

• Luc Bonnefoy, President, Surgical at Bausch + Lomb Corporation (BLCO), reported a change in beneficial ownership.
• The transaction involved the disposition of 968 common shares, no par value, on June 13, 2025.
• These shares were withheld to satisfy tax withholding obligations due upon the vesting of restricted share units.
• The price per share for the disposition was $12.33.
• Following this transaction, Mr. Bonnefoy beneficially owns 73,383 common shares directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction represents a routine, non-discretionary share withholding for tax purposes upon the vesting of restricted share units, rather than a discretionary sale or purchase.

Future Outlook

NA

Industry Context

This filing is a standard insider transaction report (Form 4) for a publicly traded company in the healthcare/medical device sector. Such filings are routine disclosures of changes in beneficial ownership by company insiders and do not typically reflect broader industry trends unless they indicate significant discretionary buying or selling activity.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of management's confidence or lack thereof in the company's future.

Key Dates

Keywords

Bausch + Lomb, BLCO, Form 4, Insider Transaction, Share Withholding, Restricted Share Units, Tax Obligations, Beneficial Ownership